BioHarvest develops stable cell culture for rare fragrance plant, completing Stage 1 program

Reuters04-01
BioHarvest develops stable cell culture for rare fragrance plant, completing Stage 1 program
  • BioHarvest Sciences completed Stage 1 of a contract development program that created a stable cell culture for a rare, endangered fragrance plant.
  • Work identified key scent molecules in the cell cultures, with molecular profiles closely matching those found in original plant material.
  • Project targets premium fragrance segment estimated at USD 23 billion within global scents and fragrances market of USD 58.9 billion.
  • Stage 1 terms give BioHarvest 20% ownership of compositions developed under program, supporting a royalty-driven CDMO model.
  • Stage 2 is expected to produce biomass for pre-commercial testing within 6 to 9 months, with industrial-scale manufacturing targeted within 12 to 18 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202603310800NEWSFILECNPR____20260331_290629_1) on March 31, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment